On March 31, 2020, Nexien BioPharma, Inc. announced that Alex Wasyl resigned as the chief executive officer and a director of the company due to personal reasons. Richard Greenberg, one of the founders of the company and an existing director, will serve as interim chief executive officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0164 USD | -21.90% | +0.61% | -36.68% |
1st Jan change | Capi. | |
---|---|---|
-36.68% | 1.11M | |
+37.58% | 727B | |
-7.89% | 354B | |
+15.61% | 328B | |
-0.50% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.83% | 164B | |
-2.07% | 164B |
- Stock Market
- Equities
- NXEN Stock
- News Nexien BioPharma, Inc.
- Nexien BioPharma, Inc. Announces Management Changes